Skip to content

ABCDEF Bundle Compliance and ICU Outcomes in Latin America

ABCDEF Bundle Compliance and Outcomes in Latin American Intensive Care Units: An International Multicenter Prospective Observational Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07783035
Enrollment
580
Registered
2026-08-24
Start date
2026-08-24
Completion date
2026-11-30
Last updated
2026-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness, Icu Delirium, Post Intensive Care Syndrome

Keywords

ABCDEF Bundle, Delirium, Intensive Care, Post Intensive Care Syndrome

Brief summary

The goal of this observational study is to evaluate the degree of compliance with the ABCDEF bundle and its relationship with clinical outcomes in adult patients (aged 18 and older) admitted to intensive care units (ICUs) in Latin America for at least 48 hours. The main questions it aims to answer are: What is the prevalence, cumulative incidence, and duration of delirium in adult ICU patients in Latin America? Is higher compliance with the ABCDEF bundle (low \[\<33%\], moderate \[33%-66%\], high \[\>66%\]) independently associated with a lower prevalence, cumulative incidence, and duration of delirium? Does higher ABCDEF bundle compliance improve functional mobility at hospital discharge and long-term cognitive, psychological, and quality-of-life outcomes at 3 and 6 months post-discharge? Researchers will compare three groups based on their level of ABCDEF bundle compliance (low \[\<33%\], moderate \[33%-66%\], and high \[\>66%\]) to see if higher bundle adherence improves delirium and long-term post-ICU functional outcomes. Participants will: Receive standard ICU care without experimental intervention. Undergo daily assessments for delirium (using CAM-ICU) and physical mobility (using ICU Mobility Scale) during their ICU stay. Complete telephone follow-up evaluations at 3 months post-discharge to assess cognitive function (BCAT-ICU/MoCA) and psychological symptoms (HADS, DSPS). Complete follow-up evaluations at 6 months post-discharge to assess cognitive function (full MoCA), psychological symptoms (HADS, DSPS), and health-related quality of life (EQ-5D-5L).

Interventions

OTHERABCDEF Bundle Compliance Assessment

Observational assessment of routine ICU clinical care practices implementing the ABCDEF bundle components (A: Sedation Assessment, B: Spontaneous Breathing Trials, C: Choice of Anesthesia/Sedation, D: Delirium Assessment and Management, E: Early Mobility, F: Family Engagement). No experimental intervention is assigned by the study protocol.

Sponsors

Hospital H+ Queretaro
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years Admission to the ICU during the 3-month recruitment period * Expected ICU length of stay ≥48 hours * Written informed consent provided by the patient or legal representative (or eligibility for deferred consent according to local regulations)

Exclusion criteria

* History of moderate to severe dementia * Severe chronic brain disease (e.g., previous disabling stroke, Parkinson's disease, advanced multiple sclerosis) * Severe prior intellectual disability or prior functional cognitive dependence * Palliative sedation scheduled from ICU admission * Deep irreversible coma or diagnosed brain death * Uncorrected bilateral deafness * Non-Spanish speakers * Refusal or explicit request by the family not to participate

Design outcomes

Primary

MeasureTime frameDescription
ICU Delirium DurationDaily during the ICU stay (up to hospital discharge or a maximum of 30 days).Total number of days with delirium during the ICU stay, calculated from daily CAM-ICU assessments.
ICU Delirium PrevalenceDaily during the ICU stay (up to hospital discharge or a maximum of 30 days)Percentage of adult patients experiencing delirium at any point during their ICU stay, evaluated daily using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU).
ICU Delirium Cumulative IncidenceDaily during the ICU stay (up to hospital discharge or a maximum of 30 days).Percentage of patients without delirium at ICU admission who subsequently develop delirium during their ICU stay, assessed daily using the CAM-ICU.

Secondary

MeasureTime frameDescription
Hospital Anxiety and Depression Scale - Anxiety Subscale at 6 Months6 months post-hospital discharge.Psychological distress regarding anxiety symptoms assessed using the Anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A). Scores range from 0 to 21, where higher scores indicate greater severity of anxiety symptoms (worse outcome).
Functional Mobility at ICU DischargeAssessed every 48 hours during the ICU stay until ICU discharge (up to 30 days)Physical mobility evaluated using the ICU Mobility Scale (ICUMS), an 11-point scale ranging from 0 (nothing/lying in bed) to 10 (walking independently without a walking aid). Higher scores represent better physical mobility and functional status.
Achievement of Standing or Walking at ICU DischargeAssessed every 48 hours during the ICU stay until ICU discharge (up to 30 days).Percentage of patients reaching a functional mobility level of at least standing at bedside or walking (defined as an ICU Mobility Scale score ≥ 4) before ICU discharge.
In-Hospital MortalityFrom ICU admission up to hospital discharge (approximately 30 days).Proportion of patients who died prior to hospital discharge.
Hospital Anxiety and Depression Scale - Depression Subscale at 6 Months6 months post-hospital discharge.Psychological distress regarding depression symptoms assessed using the Depression subscale of the Hospital Anxiety and Depression Scale (HADS-D). Scores range from 0 to 21, where higher scores indicate greater severity of depressive symptoms (worse outcome).
Post-ICU Cognitive Function at 6 Months6 months post-hospital discharge.Global cognitive performance assessed using the full Montreal Cognitive Assessment (MoCA). Scores range from 0 to 30, where higher scores represent better cognitive function (a score of 26 or above is considered normal).
Post-Traumatic Stress Symptoms at 3 Months3 months post-hospital discharge.Psychological post-traumatic stress symptoms assessed using the 17-item Davidson Trauma Scale (DSPS). Total scores range from 0 to 136, where higher scores indicate greater frequency and severity of post-traumatic stress symptoms (worse outcome).
Post-Traumatic Stress Symptoms at 6 Months6 months post-hospital discharge.Psychological post-traumatic stress symptoms assessed using the 17-item Davidson Trauma Scale (DSPS). Total scores range from 0 to 136, where higher scores indicate greater frequency and severity of post-traumatic stress symptoms (worse outcome).
EQ-5D-5L Index Score at 6 Months6 months post-hospital discharge.Self-reported health status and quality of life evaluated across 5 dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression). The index utility score ranges approximately from -0.6 to 1.0 (depending on national value sets), where higher scores represent better health-related quality of life (1.0 = perfect health).
EQ-5D Visual Analog Scale (EQ-VAS) Score at 6 Months6 months post-hospital discharge.Self-rated overall health status assessed using the EQ-5D Visual Analog Scale (EQ-VAS). Scores range from 0 to 100 mm, where 0 represents the worst health you can imagine and 100 represents the best health you can imagine (higher scores represent better outcome).
Post-ICU Cognitive Function at 3 Months3 months post-hospital dischargeGlobal cognitive performance assessed using either the BCAT-ICU or the T-MoCA. Scores range from 0 to 30 for BCAT-ICU (and 0 to 22 for T-MoCA), where higher scores indicate better cognitive performance.
Hospital Anxiety and Depression Scale - Anxiety Subscale at 3 Months3 months post-hospital discharge.Psychological distress regarding anxiety symptoms assessed using the Anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A). Scores range from 0 to 21, where higher scores indicate greater severity of anxiety symptoms (worse outcome; scores ≥ 8 suggest clinical anxiety).
Hospital Anxiety and Depression Scale - Depression Subscale at 3 Months3 months post-hospital discharge.Psychological distress regarding depression symptoms assessed using the Depression subscale of the Hospital Anxiety and Depression Scale (HADS-D). Scores range from 0 to 21, where higher scores indicate greater severity of depressive symptoms (worse outcome; scores ≥ 8 suggest clinical depression).

Contacts

CONTACTJob Heriberto Rodriguez Guillen
job.rodriguez@hospitalesmac.com5549636548

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 25, 2026